INTERNATIONAL BUSINESS MACHINES CO (IBM)

Sector: Information Technology

    Home/Companies/IBM/Annual Meeting

2026 Annual Meeting Analysis

INTERNATIONAL BUSINESS MACHINES CO · Meeting: April 28, 2026

Policy v0.7medium confidenceView Filing ↗
For informational purposes only. This AI-generated analysis applies a published voting policy to publicly available proxy filings. It does not constitute investment advice, proxy voting advice, or a solicitation of any kind. AI analysis may be incomplete or inaccurate — always review the actual filing and make your own independent decision.

Directors FOR

13

Directors AGAINST

0

Say on Pay

FOR

Auditor

FOR

Director Elections

Election of 13 directors for a term of one year

13 FOR
✓ FOR
Marianne C. Brown

Director since 2023 (under 24 months — exempt from TSR trigger); strong technology and cybersecurity background; no overboarding or attendance concerns.

✓ FOR
Thomas Buberl

IBM's 3-year total return of +114.4% outperforms the peer group median of +56.0% by +58.4pp, well above the 50pp threshold required to trigger a no-vote for strong-positive TSR; no other policy flags.

✓ FOR
David N. Farr

IBM's 3-year total return outperforms the peer group median by +58.4pp, clearing the 50pp threshold; no overboarding or attendance concerns and serves as a designated Audit Committee Financial Expert.

✓ FOR
Alex Gorsky

IBM's strong 3-year TSR outperformance clears the policy threshold; Gorsky serves as Lead Independent Director with robust governance responsibilities and no overboarding concerns.

✓ FOR
Michelle J. Howard

IBM's 3-year TSR outperforms the peer group by +58.4pp, clearing the 50pp threshold; distinguished leadership background in cybersecurity and risk management; no attendance or overboarding flags.

✓ FOR
Arvind Krishna

As CEO and executive director, Krishna is subject to the same TSR trigger; IBM's 3-year outperformance of +58.4pp over peers clears the 50pp threshold, so no TSR-based vote against applies; this recommendation is independent of the Say on Pay vote.

✓ FOR
Ramon Laguarta

Joined the board in March 2026, well within the 24-month new-director exemption from the TSR trigger; relevant expertise in global business strategy and innovation.

✓ FOR
Andrew N. Liveris

IBM's 3-year TSR outperforms the peer group by +58.4pp, clearing the 50pp threshold; serves as chair of the Directors and Corporate Governance Committee with extensive global operational experience.

✓ FOR
F. William McNabb III

IBM's strong 3-year TSR clears the performance threshold; former Vanguard CEO brings deep financial expertise; serves on UnitedHealth Group board but total board count does not trigger overboarding policy.

✓ FOR
Michael Miebach

Director since 2023; IBM's 3-year TSR outperformance clears the policy threshold; active CEO of Mastercard brings relevant digital technology and cybersecurity expertise; board seat count does not trigger overboarding.

✓ FOR
Martha E. Pollack

IBM's 3-year TSR outperforms the peer group by +58.4pp, clearing the 50pp threshold; AI and computer science expertise is highly relevant to IBM's strategy; no overboarding or attendance concerns.

✓ FOR
Peter R. Voser

IBM's 3-year TSR outperformance of +58.4pp clears the 50pp threshold; serves as Audit Committee chair and is a designated Audit Committee Financial Expert with extensive global finance experience.

✓ FOR
Alfred W. Zollar

IBM's 3-year TSR outperforms the peer group by +58.4pp, clearing the 50pp threshold; deep IBM technology background and current board roles at Nasdaq and BNY add relevant governance experience.

All 13 director nominees receive a FOR recommendation. IBM's 3-year total shareholder return of +114.4% outperforms the disclosed compensation peer group median of +56.0% by +58.4 percentage points, which exceeds the 50pp underperformance threshold required to trigger a no-vote under the strong-positive TSR tier — meaning the TSR trigger does not fire for any director. Newly appointed director Ramon Laguarta is additionally exempt as a director who joined within the past 24 months. No director triggers the overboarding rule, attendance concerns, independence issues on sensitive committees, or familial relationship flags.

Say on Pay

✓ FOR

CEO

A. Krishna

Total Comp

$37,989,685

Prior Support

92%%

IBM's CEO received total compensation of approximately $38 million in 2025, which is elevated for the technology sector at IBM's market cap band but is driven heavily by variable, performance-linked pay — approximately 95% of Mr. Krishna's target compensation was at-risk, consisting of performance stock awards, stock options, and an annual bonus tied to revenue and cash flow targets. IBM's 3-year total shareholder return of +114.4% substantially outperforms its peer group median of +56.0%, meaning the above-benchmark incentive pay was earned in the context of strong shareholder outcomes, satisfying the pay-for-performance alignment check. The program has meaningful safeguards including robust clawback provisions, no guaranteed payouts, no repricing of options, and a newly introduced relative TSR modifier for the long-term plan, and the prior year's Say on Pay vote received 92% support — well above the 70% threshold that would require corrective action.

Auditor Ratification

✓ FOR

Auditor

PricewaterhouseCoopers LLP

Tenure

N/A

Audit Fees

N/A

Non-Audit Fees

N/A

PricewaterhouseCoopers is a Big 4 firm fully appropriate for a company of IBM's size and complexity. The proxy filing does not provide a clear, parseable fee table with specific dollar amounts for audit versus non-audit fees in the extracted text provided, so the non-audit fee ratio trigger cannot be confirmed as breached; per policy, the tenure trigger requires confirmed data to fire and tenure is not explicitly stated in the provided text, so no tenure-based no-vote is warranted. No material financial restatements are disclosed. On the available evidence, no policy trigger for a no-vote is met.

Stockholder Proposals

4 proposals submitted by shareholders

Proposal 5

Stockholder proposal requesting a change to IBM's outside director stock ownership guidelines

✗ AGAINST
Filed by:Theron Marshall HoytOtherGovernance
Board recommends: AGAINST
company existing policy substantially addresses concerndeferred shares economically equivalent to common stock

This proposal asks IBM to require outside directors to personally own actual shares of IBM stock (not just deferred stock units) in some meaningful amount. While the underlying concern about director skin-in-the-game alignment is legitimate in principle, IBM's existing policy already requires directors to hold IBM stock-based holdings worth eight times the equity portion of their annual retainer within five years — one of the strongest requirements among large U.S. companies. The deferred stock units (Promised Fee Shares) that count toward this requirement are economically identical to owning IBM shares — they rise and fall with the stock price, earn dividend equivalents, and cannot be sold until the director leaves the board, which actually creates stronger alignment than freely tradable shares. There is no prior-year vote history to suggest sustained shareholder concern, the filer is an individual retail investor without a track record of governance activism, and IBM's response credibly addresses the core issue.

Proposal 6

Stockholder proposal requesting a right to act by written consent

✓ FOR
Filed by:John CheveddenIndividual ActivistGovernance
Prior-year support: 43% (43% support at the 2024 IBM annual meeting)
Board recommends: AGAINST
43% prior year supportindividual governance activist filergovernance structural ask

This proposal comes from John Chevedden, a well-known individual governance activist with a strong track record of filing legitimate shareholder rights proposals, and it received 43% support at the 2024 annual meeting — a very strong signal that a substantial portion of IBM's shareholders, including major institutional investors with access to independent proxy advice, view this as a real governance concern. Under our policy, 40-50% prior-year support creates a lean-FOR default, and the company has not made any structural changes in response. The ask — allowing shareholders who together own a majority of shares to take action between annual meetings without waiting for a special meeting — is a mainstream governance right that more than half of S&P 500 companies already provide, and IBM's 25% special meeting threshold (which the proponent credibly argues is functionally unreachable at a $232 billion company) does not adequately substitute for this right.

Proposal 7

Stockholder proposal requesting a report on AI bias

✗ AGAINST
Filed by:National Center for Public Policy ResearchIdeological — ConservativeDisclosure
Board recommends: AGAINST
ideological conservative filerpolitical motivation disqualifies proposal

The National Center for Public Policy Research (NCPPR) is a well-documented conservative ideological advocacy organization, not a neutral fiduciary investor — under our policy, proposals from ideological filers on either side of the political spectrum are voted against regardless of how the proposal is framed, because they serve political goals rather than shareholder interests. The framing of this proposal — invoking a White House executive order on 'woke AI' and citing concerns about 'left-leaning slant' in AI models — makes clear this is political advocacy dressed as a shareholder request, not a genuine fiduciary risk assessment. IBM also credibly demonstrates that the information sought already exists in publicly available form, including a top 95% transparency score from Stanford's Foundation Model Transparency Index.

Proposal 8

Stockholder proposal requesting a report on discrimination in charitable support

✗ AGAINST
Filed by:The Heritage Foundation, represented by Bowyer ResearchIdeological — ConservativeDisclosure
Board recommends: AGAINST
ideological conservative filerpolitical motivation disqualifies proposal

The Heritage Foundation is a prominent conservative political advocacy organization — its proposal, submitted through Bowyer Research (a known vehicle for ideologically motivated corporate governance campaigns), is directed at IBM's LGBTQ+ healthcare and charitable policies and uses explicitly political framing referencing 'transgender activism,' the Human Rights Campaign, and the 'Good for Business Coalition.' Under our policy, proposals from ideological filers on either side of the political spectrum are voted against because they serve political advocacy goals, not the financial interests of shareholders. IBM's charitable initiatives (skills training, environmental community support, employee giving) are not financially material to IBM's business, are already disclosed in detail, and are not the kind of ordinary business decisions that shareholders should micromanage through annual meeting proposals.

Overall Assessment

IBM's 2026 annual meeting ballot is broadly clean from a governance perspective — the company's strong 3-year total shareholder return outperforms its peer group by a wide margin, the Say on Pay program is heavily performance-linked with 92% prior-year support, and PricewaterhouseCoopers remains an appropriate auditor. The one meaningful governance concern on the ballot is Proposal 6 (written consent), which attracted 43% support in 2024 from a credible activist filer and has not been addressed by the company, warranting a FOR vote despite the board's opposition.

Filing date: March 10, 2026·Policy v0.7·medium confidence

Compensation Peer Group

22 companies disclosed in 2026 proxy filing

ACNAccenture
ADBEAdobe
GOOGLAlphabet
AMZNAmazon.com
TAT&T
BACBank of America
BABoeing
AVGOBroadcom
CSCOCisco Systems
ELVElevance Health
HPEHewlett Packard Enterprise
HONHoneywell
INTCIntel
MSFTMicrosoft
ORCLOracle
PEPPepsiCo
QCOMQualcomm
RTXRTX
CRMSalesforce
UPSUPS
VZVerizon
VVisa